Novartis AG
COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS
Last updated:
Abstract:
The invention provides compounds of Formula (I), immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat diseases or disorders associated with Toll-Like Receptor 7 activity. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
24 Jul 2019
Issue date:
14 Nov 2019